Health

In the United States, the demand for monoclonal antibodies to treat Covid, Health News, and ETHealthWorld is skyrocketing.

Washington: Monoclonal antibodies are in high demand for Covid treatment in the United States, especially for those who refuse vaccines against infectious diseases, urging the Joe Biden administration to impose new restrictions on drug orders, the media said. The press says.

Overall, the demand for monoclonal antibody therapy, a laboratory-made antibody given to those who help the immune system stop the spread of the infection, has increased 20-fold since mid-July, CBS News reported. ..

Alabama, Florida, Texas, Mississippi, Tennessee, Georgia, and Louisiana have accounted for 70% of monoclonal antibody orders in recent weeks, according to a spokesman for the Department of Health and Human Services (HHS).

Of these states, only Florida is fully vaccinated to more than half of the total population, according to the Centers for Disease Control and Prevention.

Others are ranked in the bottom 10 states of vaccination nationwide.

According to the report, all seven are ranked in the top half of the state, with the highest daily hospitalization rates for Covid-19 in recent weeks.

“Given this reality, we must strive to ensure that the supply of these life-saving therapies remains available in all states and territories, not just some.” The spokesman was reported to have said.

President Biden announced last week that his administration would increase the pace of free weekly shipments of monoclonal antibodies in September by 50 percent, CNET reported.

The government has also set up a “monoclonal antibody strike team” to assist healthcare professionals and hospital staff in managing treatment.

According to the report, the HHS ministry will revise the rules to allow more healthcare providers, including pharmacists, to carry out treatment.

There is also a demand for treatment with a combination of Regeneron’s REGEN-COV and Eli Lilly’s banmulanibimab and etesebimab, allocating drugs to the state health department “based on the Covid-19 case burden”.

According to some preliminary studies, this treatment (a combination of REGEN-COV from Regeneron and Eli Lilly’s banmuranibimab and etesebimab) reduces the risk of hospitalization or death by about 70%.

In early August, the president’s chief medical adviser, Anthony Fauci, said that monoclonal antibodies were “underutilized” and that the drug could reduce the risk of hospitalization or death from Covid-19 by 70-85%. Said.

However, it cannot be used as a “substitute for vaccination”. However, there is a lack of awareness and access to monoclonal antibody therapy.

This treatment is also available in India and has been successfully treated by hospitals such as Gurgaon’s Medanta, BLK-Max Super Specialty and Sirgangalam in New Delhi.



In the United States, the demand for monoclonal antibodies to treat Covid, Health News, and ETHealthWorld is skyrocketing.

Source link In the United States, the demand for monoclonal antibodies to treat Covid, Health News, and ETHealthWorld is skyrocketing.

Related Articles

Back to top button